Resmed has pioneered innovations in respiratory therapy, including CPAP therapy and digital health solutions. The company’s last major brand update in 2014 marked its shift to connectivity, ...

Resmed (NYSE: RMD) announced today that it began a comprehensive brand evolution to unify its brand portfolio.

Resmed (RMD) announced a comprehensive brand evolution designed to unify its brand portfolio to serve more people and healthcare providers ...

ResMed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

ResMed showed 29% EPS growth last quarter. Sales gains came in at 10%. ResMed earns the No. 6 rank among its peers in the Medical-Products industry group. Boston Scientific, Penum ...

Shares of ResMed Inc. RMD advanced 3.29% to $232.44 Friday, on what proved to be an all-around positive trading session for ...

These 2 ASX growth stocks have multiple buy ratings from top brokers as we stroll through 2025. Let's dive in and see.

StockNews.com cut shares of ResMed (NYSE:RMD – Free Report) from a buy rating to a hold rating in a research note published on Friday morning. Several other equities analysts have also issued reports ...

A new survey finds that 33% of Singaporeans suffer from poor sleep—affecting productivity, relationships, and well-being.

Shares of ResMed Inc. RMD rallied 1.80% to $236.63 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 2.70% to 5,614.56 and Dow ...

Brand Evolution Unites Brands Under One Resmed Identity to Make Better Sleep and Breathing Health More Accessible to EveryoneSAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), ...